ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis
USA - NASDAQ:ICHR - KYG4740B1059 - Common Stock
21.05 USD
-1.48 (-6.57%)
21 USD
-0.05 (-0.24%)
We assign a fundamental rating of 4 out of 10 to ICHR. ICHR was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. ICHR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICHR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ICHR had positive earnings in the past year.
In the past year ICHR had a positive cash flow from operations.
In multiple years ICHR reported negative net income over the last 5 years.
ICHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of ICHR (-2.10%) is worse than 60.71% of its industry peers.
With a Return On Equity value of -2.98%, ICHR perfoms like the industry average, outperforming 41.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.1% | ||
| ROE | -2.98% | ||
| ROIC | N/A |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ICHR has a worse Gross Margin (11.89%) than 87.50% of its industry peers.
In the last couple of years the Gross Margin of ICHR has declined.
The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.89% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ICHR has been increased compared to 1 year ago.
Compared to 5 years ago, ICHR has more shares outstanding
The debt/assets ratio for ICHR has been reduced compared to a year ago.
2.2 Solvency
ICHR has an Altman-Z score of 3.02. This indicates that ICHR is financially healthy and has little risk of bankruptcy at the moment.
ICHR's Altman-Z score of 3.02 is in line compared to the rest of the industry. ICHR outperforms 44.64% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
The Debt to Equity ratio of ICHR (0.17) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.02 |
ROIC/WACCN/A
WACC11.4%
2.3 Liquidity
ICHR has a Current Ratio of 3.22. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
ICHR has a Current ratio of 3.22. This is comparable to the rest of the industry: ICHR outperforms 57.14% of its industry peers.
A Quick Ratio of 1.32 indicates that ICHR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.32, ICHR is not doing good in the industry: 80.36% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.22 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1266.67% over the past year.
ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.82% yearly.
ICHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.44%.
The Revenue has been growing slightly by 6.46% on average over the past years.
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%
3.2 Future
ICHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.13% yearly.
Based on estimates for the next years, ICHR will show a quite strong growth in Revenue. The Revenue will grow by 8.59% on average per year.
EPS Next Y157.12%
EPS Next 2Y162.91%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 60.14, the valuation of ICHR can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as ICHR.
ICHR is valuated expensively when we compare the Price/Earnings ratio to 27.57, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.03 indicates a rather expensive valuation of ICHR.
Based on the Price/Forward Earnings ratio, ICHR is valued cheaper than 81.25% of the companies in the same industry.
ICHR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.14 | ||
| Fwd PE | 19.03 |
4.2 Price Multiples
ICHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ICHR is cheaper than 63.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 32.18 |
4.3 Compensation for Growth
ICHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICHR's earnings are expected to grow with 106.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y162.91%
EPS Next 3Y106.44%
5. Dividend
5.1 Amount
No dividends for ICHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.05
-1.48 (-6.57%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners98.94%
Inst Owner Change0.57%
Ins Owners2.1%
Ins Owner Change21.13%
Market Cap722.65M
Revenue(TTM)929.18M
Net Income(TTM)-20686000
Analysts78.46
Price Target24.65 (17.1%)
Short Float %7.73%
Short Ratio2.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-67.14%
Min EPS beat(2)-79.27%
Max EPS beat(2)-55.02%
EPS beat(4)1
Avg EPS beat(4)-33.43%
Min EPS beat(4)-79.27%
Max EPS beat(4)10.09%
EPS beat(8)2
Avg EPS beat(8)-597.61%
EPS beat(12)5
Avg EPS beat(12)-369.48%
EPS beat(16)6
Avg EPS beat(16)-277.99%
Revenue beat(2)1
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)0.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)0%
PT rev (3m)-20.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50.57%
EPS NY rev (1m)-9.6%
EPS NY rev (3m)-47.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.14 | ||
| Fwd PE | 19.03 | ||
| P/S | 0.78 | ||
| P/FCF | N/A | ||
| P/OCF | 42.38 | ||
| P/B | 1.04 | ||
| P/tB | 2.3 | ||
| EV/EBITDA | 32.18 |
EPS(TTM)0.35
EY1.66%
EPS(NY)1.11
Fwd EY5.25%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.5
OCFY2.36%
SpS27.07
BVpS20.22
TBVpS9.15
PEG (NY)0.38
PEG (5Y)N/A
Graham Number12.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.1% | ||
| ROE | -2.98% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.89% | ||
| FCFM | N/A |
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.01 | ||
| Cap/Depr | 115.9% | ||
| Cap/Sales | 3.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 72.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.22 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 3.02 |
F-Score6
WACC11.4%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1266.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-40%
EPS Next Y157.12%
EPS Next 2Y162.91%
EPS Next 3Y106.44%
EPS Next 5Y73.13%
Revenue 1Y (TTM)15.44%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%18.23%
Revenue Next Year12.47%
Revenue Next 2Y9.09%
Revenue Next 3Y8.94%
Revenue Next 5Y8.59%
EBIT growth 1Y59.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year222.78%
EBIT Next 3Y56.45%
EBIT Next 5Y48.64%
FCF growth 1Y-139.16%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-77.09%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%